Antineoplaston Therapy in Treating Patients With Soft Tissue Sarcoma

Summary

Current therapies for Soft Tissue Sarcoma provide very limited benefit to the patient. The anti-cancer properties of Antineoplaston therapy suggest that it may prove beneficial in the treatment of Soft Tissue Sarcoma. PURPOSE: This study is being performed to determine the effects (good and bad) that Antineoplaston therapy has on patients with Soft Tissue Sarcoma.

Timeline

Start

1996-06-14

Primary completion

2003-08-30

Completion

2003-08-30

Drugs

Indications